| Literature DB >> 24586983 |
Joana M Haussig1, Kai Matuschewski2, Taco W A Kooij1.
Abstract
Iron-sulfur [Fe-S] clusters are ubiquitous and critical cofactors in diverse biochemical processes. They are assembled by distinct [Fe-S] cluster biosynthesis pathways, typically in organelles of endosymbiotic origin. Apicomplexan parasites, including Plasmodium, the causative agent of malaria, harbor two separate [Fe-S] cluster biosynthesis pathways in the their mitochondrion and apicoplast. In this study, we systematically targeted the five nuclear-encoded sulfur utilization factors (SUF) of the apicoplast [Fe-S] cluster biosynthesis pathway by experimental genetics in the murine malaria model parasite Plasmodium berghei. We show that four SUFs, namely SUFC, D, E, and S are refractory to targeted gene deletion, validating them as potential targets for antimalarial drug development. We achieved targeted deletion of SUFA, which encodes a potential [Fe-S] transfer protein, indicative of a dispensable role during asexual blood stage growth in vivo. Furthermore, no abnormalities were observed during Plasmodium life cycle progression in the insect and mammalian hosts. Fusion of a fluorescent tag to the endogenous P. berghei SUFs demonstrated that all loci were accessible to genetic modification and that all five tagged SUFs localize to the apicoplast. Together, our experimental genetics analysis identifies the key components of the SUF [Fe-S] cluster biosynthesis pathway in the apicoplast of a malarial parasite and shows that absence of SUFC, D, E, or S is incompatible with Plasmodium blood infection in vivo.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24586983 PMCID: PMC3931816 DOI: 10.1371/journal.pone.0089718
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Confirmed and predicted [Fe-S] cluster-containing proteins in Plasmodium.
|
|
| Annotation | PlasmoAP | ApicoAP | PlasMit | MitoProtII |
|
| ||||||
| PBANKA_020870 | PF3D7_0104400 | IspH/LytB, 4-hydroxy-3-methylbut-2-enyl diphosphate reductase | −/− | no SP | possibly | 0.5404 |
| PBANKA_050700 | PF3D7_1022800 | IspG/GcpE, 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase | +/++ | ATP | non-mito | 0.8285 |
| PBANKA_070700 | PF3D7_0823600 | LipB, lipoate-protein ligase | +/++ | no SP | non-mito | 0.9748 |
| PBANKA_081190 | PF3D7_0910800 | nucleotide binding protein, putative | ++/++ | ATP | non-mito | 0.9760 |
| PBANKA_112110 | PF3D7_0622200 | radical SAM protein, putative | +/++ | ATP | non-mito | 0.9952 |
| PBANKA_135750 | PF3D7_1344600 | LipA, lipoyl synthase | ++/++ | ATP | non-mito | 0.6838 |
| PBANKA_141660 | PF3D7_1318100 | ferredoxin, putative | ++/++ | ATP | non-mito | 0.8117 |
|
| ||||||
| PBANKA_061790 | PF3D7_0720400 | ferrodoxin reductase-like protein | −/++ | no SP | possibly | 0.8670 |
| PBANKA_082810 | PF3D7_0927300 | fumarat hydratase, putative | −/++ | no SP | non-mito | 0.8939 |
| PBANKA_090930 | PF3D7_1139700 | adrenodoxin reductase, putative | −/+ | no SP | possibly | 0.0610 |
| PBANKA_122950 | PF3D7_0614800 | endonuclease III homologue, putative | −/++ | no SP | non-mito | 0.5453 |
| PBANKA_130330 | PF3D7_1439400 | ubiquinol-cytochrome c reductase iron-sulfur subunit, putative | −/++ | no SP | possibly | 0.9782 |
| PBANKA_135520 | PF3D7_1342100 | aconitate hydratase | −/++ | no SP | possibly | 0.8460 |
| PBANKA_142880 | PF3D7_1212800 | iron-sulfur subunit of succinate dehydrogenase | −/++ | no SP | possibly | 0.1521 |
| PBANKA_143040 | PF3D7_1214600 | adrenodoxin-type ferredoxin, putative | −/++ | no SP | possibly | 0.8299 |
|
| ||||||
| PBANKA_011240 | PF3D7_0614200 | conserved Plasmodium protein, unknown function | −/− | no SP | non-mito | 0.0141 |
| PBANKA_083490 | PF3D7_0934100 | XPD/ERCC2, DNA excision-repair helicase, putative | −/− | no SP | non-mito | 0.0106 |
| PBANKA_091970 | PF3D7_1128500 | conserved protein, unknown function | −/− | non-mito | 0.1301 | |
| PBANKA_101520 | PF3D7_1429500 | diphthamide synthesis protein, putative | −/− | no SP | non-mito | 0.2517 |
| PBANKA_102890 | PF3D7_1413800 | diphthamide synthesis protein, putative | −/− | no SP | possibly | 0.0176 |
| PBANKA_103410 | PF3D7_1408400 | DNA-repair helicase, putative | −/− | no SP | possibly | 0.0139 |
| PBANKA_103530 | PF3D7_1406900 | radical SAM protein, putative | −/+ | no SP | possibly | 0.1722 |
| PBANKA_133970 | PF3D7_1324500 | DEAD box helicase, putative | −/− | no SP | non-mito | 0.4691 |
|
| ||||||
| PBANKA_011230 | PF3D7_0614100 | conserved Plasmodium protein, unknown function | −/++ | no SP | possibly | 0.2399 |
| PBANKA_070600 | PF3D7_0824600 | anamorsin related protein, putative | −/− | no SP | non-mito | 0.1138 |
| PBANKA_081200 | PF3D7_0910900 | DNA primase large subunit, putative | −/++ | no SP | possibly | 0.0509 |
| PBANKA_090570 | PF3D7_1143300 | DNA-directed RNA polymerase I, putative | −/− | no SP | non-mito | 0.0677 |
| PBANKA_100950 | PF3D7_1435300 | NAD(P)H-dependent glutamate synthase, putative | −/− | no SP | non-mito | 0.0131 |
| PBANKA_114410 | PF3D7_1368200 | RNAse L inhibitor protein, putative | −/− | no SP | possibly | 0.0535 |
| PBANKA_123970 | PF3D7_0524900 | tRNA-YW synthesizing protein, putative | −/0 | no SP | non-mito | 0.0527 |
| PBANKA_144250 | PF3D7_1227800 | histone S-adenosyl methyltransferase, putative | −/− | no SP | non-mito | 0.0660 |
Gene IDs of the P. berghei and P. falciparum orthologs and the predicted localizations of the proteins were retrieved from PlasmoDB (http://PlasmoDB.org) or identified by similarity searches using A. thaliana [Fe-S] cluster proteins as query sequences [41].
Putative targeting of the P. falciparum [Fe-S] cluster-containing proteins to the apicoplast or mitochondrion was predicted using four different algorithms. PlasmoAP [51] indicates the likelihood of the presence of the required signal peptide followed by the likelihood of an apicoplast localization (“−” = unlikely, “0″ = undecided, “+” = likely, “++” = very likely). ApicoAP [52] is a different algorithm that can identify apicoplast proteins in multiple Apicomplexa (“No SP” = no signal peptide, “No ATP” = signal peptide but no transit peptide, “ATP” = apicoplast targeted protein). PlasMit [53] predicts the likelihood of a mitochondrial localization for P. falciparum proteins (“non-mito” (99%), “possibly” (91%), and “mito” (99%)). MitoProtII [54] gives a probability score for the likelihood of mitochondrial localization but is not optimized for Plasmodium sequences.
Figure 1Systematic gene targeting of Plasmodium berghei SUF genes.
(A) Replacement strategy to delete the five nuclear-encoded PbSUF genes. The respective ANKA strain wild type (WT) SUF loci were targeted with replacement plasmids (pKO) containing upstream 5′ and downstream 3′ regions (dark gray bars) flanking the open reading frames (light gray arrow), a high-expressing GFP cassette (green), and the hDHFR-yFcu drug-selectable cassette (blue). Integration-specific (5′INT and 3′INT) and wild type-specific (5′WT and 3′WT) primer combinations (Table S1) are indicated by arrows; expected PCR fragments by dotted lines. The probe used for Southern blot analysis of the two isogenic sufA – parasites lines corresponds to the 5′ integration sequence and hybridized to EcoRI (E) restriction-digested gDNA; expected fragments and their sizes are indicated by gray dashed lines. (B) Representative diagnostic PCR results of the SUF loci of WT ANKA (pre transfection) and drug-selected (post transfection) parasites are shown. For SUFA, diagnostic PCR of isogenic gene deletion parasites confirms successful integration and absence of WT parasite contamination. (C) Overview of all transfection experiments summarizing the number of times no pyrimethamine-resistant parasites were selected (black), selection of pyrimethamine-resistant parasites was achieved (red), integration-specific PCR demonstrated targeted deletion of the SUF gene (orange), and isolation of WT-free, isogenic recombinant parasites (green). (D) Southern blot analysis of two isogenic sufA – parasite lines reveals the expected size shifts.
Figure 2SUFA is dispensable for blood infection in vivo.
Parasitemias of sufA –-infected animals in comparison to mice infected with wild type (WT) parasites. Female C57BL/6 mice (WT, n = 3; sufA –1 and 2, n = 5 each) were injected intravenously with 10,000 freshly dissected salivary gland sporozoites and infection was monitored by microscopic examination of Giemsa-stained blood films. The two isogenic sufA – parasite lines (brown and orange lines) and WT parasites (gray line) showed equal pre-patent periods (three days) and similar exponential parasite growth (P>0.05; two-way ANOVA followed by Bonferroni posttests).
Figure 3Normal development of sufA – parasites in the mosquito vector and during liver cell infection.
(A) Percentage of A. stephensi mosquitoes infected with WT (gray, n = 4) and sufA – (brown, n = 6) parasites. Shown is the mean percentage (± S.D.) from independent mosquito feeding experiments. For sufA – infections, both isogenic strains, sufA –1 (n = 4) and sufA –2 (n = 2), were transmitted to mosquitoes and data combined. (B) Mean sporozoite number (± S.D.) in salivary glands (days 17–21 after infection) from the same independent mosquito feedings as shown in panel A (WT, n = 4; pooled sufA –, n = 6). (C) Liver stages development of WT and sufA – parasites in cultured hepatoma cells. Shown are mean numbers (± S.D.) of intracellular parasites at the time points indicated from two experiments done in quadruplicate each. (D) Merosome formation at 72 h after infection. Shown are mean values (± S.D.). None of the sufA – data points were significantly different from the corresponding WT values (P>0.05; non-parametric, two-tailed Mann-Whitney’s test).
Figure 4Control transfections of Plasmodium berghei SUF genes and generation of fluorescently tagged SUF parasite lines.
(A) Replacement strategy to generate stable parasite lines that express the endogenous SUF proteins fused to an mCherry-3xMyc tag (red). The respective ANKA strain wild type (WT) SUF loci were targeted with replacement plasmids (pSUF-Tag) containing carboxy terminal (CT) and downstream 3′ regions (dark gray bars), a high-expressing GFP cassette (green), and the hDHFR-yFcu drug-selectable cassette (blue). Integration-specific (CT INT and 3′INT) and wild type-specific (CT WT and 3′WT) primer combinations (Table S1) and expected fragments are indicated by arrows and dotted lines, respectively. (B) PCR-based genotyping of the suf::tag parasites to verify successful fusion of the respective SUF genes with the mCherry-3xMyc tag and WT-free isolation of the recombinant suf::tag parasites. Note that the 3′ WT- and integration-specific PCRs are identical to those designed for targeted gene deletion (Figure 1).
Figure 5Localization of Plasmodium berghei SUFs to the apicoplast in blood stages.
(A) Epifluorescent micrographs of live suf::tag parasite-infected mouse erythrocytes. Shown are representative micrographs of trophozoite stage parasites. The parasite cytoplasm is labeled by GFP and parasite nuclei by the DNA-dye Hoechst. Bars, 2 µm. (B) Co-staining of fixed trophozoite stage suf::tag parasites using anti-mCherry antibodies and anti-sera against acyl carrier protein (ACP), a signature protein of the apicoplast. Substantial overlap can be observed between the SUF::tag proteins and the signature apicoplast protein in a small structure, i.e. the apicoplast. The outlines of the parasite and the infected red blood cell (RBC) are indicated by white and magenta dotted lines, respectively. Nuclei were stained with the DNA-dye Hoechst. Bars, 2 µm.
Figure 6Localization of Plasmodium berghei SUFD, E, and S to the apicoplast in liver stages.
(A) Co-staining of fixed, sufD::tag, sufE::tag, or sufS::tag parasite-infected hepatoma cells 48 h after sporozoite infection using anti-mCherry antibodies and anti-sera against acyl carrier protein (ACP). Note substantial overlap between the SUF::tag proteins and the signature apicoplast protein. (B) Drug treatment of suf::tag-infected hepatoma cells to corroborate apicoplast localization of the SUF::tag proteins. During liver stage development suf::tag-infected cells were left untreated (control) or treated with 1 µM azithromycin. Liver stages were stained with anti-mCherry antibodies and anti-sera against upregulated in infective sporozoite protein 4 (UIS4), a signature protein of the parasitophorous vacuolar membrane (PVM). Nuclei were stained with the DNA-dye Hoechst. Bars, 10 µm.